Market revenue in 2023 | USD 1,215.5 million |
Market revenue in 2030 | USD 1,258.0 million |
Growth rate | 0.5% (CAGR from 2023 to 2030) |
Largest segment | Immunoturbidimetric assay |
Fastest growing segment | Immunoturbidimetric Assay |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoturbidimetric Assay, Chemiluminescence Immunoassay, Other Assay Types, ELISA |
Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Danaher Corp, Quest Diagnostics Inc, Siemens Healthineers AG ADR, Abbott Laboratories, Merck KGaA, Zoetis Inc Class A, QuidelOrtho Corp, Horiba Ltd, Getein Biotech, Boditech Med, Randox, Aidian |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to c-reactive protein testing market will help companies and investors design strategic landscapes.
Immunoturbidimetric assay was the largest segment with a revenue share of 48.59% in 2023. Horizon Databook has segmented the Asia Pacific c-reactive protein testing market based on immunoturbidimetric assay, chemiluminescence immunoassay, other assay types, elisa covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is projected to grow at the fastest pace even if the global market is not marled by substantial development and growth. Growing geriatric population in the region, increasing incidence of chronic diseases, and rising number of research studies pertaining to CRP testing are factors that can be attributed to the market growth.
Moreover, supportive government policies, well-developed healthcare infrastructure, and collaborations among public-private market players are also driving the progressions in the market.
Furthermore, the study on weight gain trajectories associated with elevated C-reactive protein levels in Chinese adults is predicted to further drive the progressions in the market. This study was conducted by researchers at National Institute for Nutrition and Health, China Center for Disease Control in association with other institutions.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific c-reactive protein testing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific c-reactive protein testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account